Cost-effectiveness of combination chemotherapy (oxaliplatin or irinorecan in combination with 5-FU/FA) compared with 5 FU/FA

Nick Freemantle, C Nicholls, John Cassidy, M Harrison, P Carita

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)115-25
    Number of pages11
    JournalJournal of Medical Economics
    Volume4
    Publication statusPublished - 1 Jan 2001

    Cite this